Vitamin D receptor gene polymorphisms role in COVID‐19 severity: Results of a Mexican patients’ cohort
International Journal of Immunogenetics · 2024
DOI: 10.1111/iji.12674 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Immunogenetics, 2024. Verfasst von Luis Antonio Ochoa-Ramírez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospital General de Culiacán, Servicios de Salud de Sinaloa, Culiacan, Mexico. Hauptthemen laut MEDLINE: Receptors, Calcitriol, COVID-19, Polymorphism, Single Nucleotide, Severity of Illness Index. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Vitamin D status has been involved with coronavirus disease 19 (COVID‐19) severity. This may be mediated by vitamin D metabolism regulatory genes. Of interest is the vitamin D receptor (VDR) gene, which has been previously associated with other inflammatory and respiratory diseases. In order to investigate the role of VDR gene polymorphisms in COVID‐19 severity and outcome, a total of 292 COVID‐19 patients were classified according to severity in moderate ( n = 56), severe ( n = 89) and critical ( n = 147) and, according to outcome in survivor ( n = 163) and deceased ( n = 129), and analysed for Fok I and Taq I VDR gene polymorphisms by polymerase chain reaction‐based restriction enzyme digestion. The Fok I and Taq I single nucleotide polymorphisms (SNPs) were not associated with COVID‐19 severity or mortality individually but when analysed by haplotype, TC was associated with an increased risk of presenting critical COVID‐19. Additionally, Fok I CT genotype was more frequent in COVID‐19 patients with hypertension, and T allele carriers presented higher aspartate aminotransferase levels. Our results suggest a relationship between VDR Fok I and Taq I SNPs and COVID‐19 severity in Mexican population. Although there are some previous reports of VDR polymorphisms in COVID‐19, this represents the first report in Latin American population. Further studies on other populations are encouraged.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital General de Culiacán, Servicios de Salud de Sinaloa, Culiacan, Mexico.
- Maestría en Ciencias Biomédicas, Facultad de Ciencias Químico Biológicas, Culiacan, Mexico.
- Centro de Investigación y Docencia en Ciencias de la Salud, Culiacan, Mexico.
- Facultad de Biología, Universidad Autónoma de Sinaloa, Culiacán, Sinaloa, Mexico.
- Departamento de Aparatos y Sistemas II, Universidad Autónoma de Guadalajara, Zapopan, Jalisco, México.
ORCID-Profile: Luis Antonio Ochoa-Ramírez, Denisse Stephania Becerra-Loaiza
Zitieren
APA
Ochoa-Ramírez, L. A., Corona-Angulo, A. L., Ríos-Burgueño, E. R., Sánchez-Zazueta, J. G., Becerra-Loaiza, D. S., & Velarde-Félix, J. S. (2024). Vitamin D receptor gene polymorphisms role in COVID‐19 severity: Results of a Mexican patients’ cohort. International Journal of Immunogenetics. https://doi.org/10.1111/iji.12674
Vancouver
Ochoa-Ramírez LA, Corona-Angulo AL, Ríos-Burgueño ER, Sánchez-Zazueta JG, Becerra-Loaiza DS, Velarde-Félix JS. Vitamin D receptor gene polymorphisms role in COVID‐19 severity: Results of a Mexican patients’ cohort. International Journal of Immunogenetics. 2024. doi:10.1111/iji.12674
BibTeX
@article{OchoaRamrez2024,
author = {Ochoa-Ramírez, Luis Antonio and Corona-Angulo, Alba Lissy and Ríos-Burgueño, Efrén Rafael and Sánchez-Zazueta, Jorge Guillermo and Becerra-Loaiza, Denisse Stephania and Velarde-Félix, Jesús Salvador},
title = {Vitamin D receptor gene polymorphisms role in COVID‐19 severity: Results of a Mexican patients’ cohort},
journal = {International Journal of Immunogenetics},
year = {2024},
doi = {10.1111/iji.12674}
}
EUVIMED